Biomarkers of Bad Biology: Curse or a Blessing?
作者信息
Banerjee Sudeep, Sicklick Jason K
机构信息
Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, USA.
Department of Surgery, University of California, Los Angeles, Los Angeles, USA.
出版信息
Ann Surg Oncol. 2019 Feb;26(2):318-320. doi: 10.1245/s10434-018-07105-w. Epub 2018 Dec 11.
Abstract
摘要
相似文献
1
Biomarkers of Bad Biology: Curse or a Blessing?不良生物学的生物标志物：祸还是福？
Ann Surg Oncol. 2019 Feb;26(2):318-320. doi: 10.1245/s10434-018-07105-w. Epub 2018 Dec 11.
2
Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity.新药预测性生物标志物组合的共同开发算法：考虑患者间和患者内肿瘤异质性。
Clin Lung Cancer. 2012 Sep;13(5):321-5. doi: 10.1016/j.cllc.2012.05.004. Epub 2012 Jun 6.
3
Editorial comment.编辑评论。
Curr Opin Urol. 2017 Jan;27(1):34. doi: 10.1097/MOU.0000000000000358.
4
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics.旧药新用：细胞毒化疗药物耐药性。
Drug Resist Updat. 2016 Sep;28:65-81. doi: 10.1016/j.drup.2016.07.001. Epub 2016 Jul 16.
5
Rare Mutations in Cancer Drug Resistance and Implications for Therapy.癌症耐药中的罕见突变及其对治疗的影响
Clin Pharmacol Ther. 2020 Sep;108(3):437-439. doi: 10.1002/cpt.1938. Epub 2020 Jul 10.
6
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.患者来源肿瘤细胞的药物基因组学全景分析为精准肿瘤治疗提供信息。
Nat Genet. 2018 Oct;50(10):1399-1411. doi: 10.1038/s41588-018-0209-6. Epub 2018 Sep 27.
7
Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.不仅是 P-糖蛋白：ABCB1 所在的染色体区域 7q21 的扩增通过协调过表达一系列耐药相关蛋白赋予癌细胞多药耐药性。
Drug Resist Updat. 2017 May;32:23-46. doi: 10.1016/j.drup.2017.10.003. Epub 2017 Oct 16.
8
Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!细胞表型调控和重编程的数学模型：让癌细胞再次变得敏感！
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):167-175. doi: 10.1016/j.bbcan.2017.04.001. Epub 2017 Apr 7.
9
Drug resistance, epigenetics, and tumor cell heterogeneity.耐药性、表观遗传学和肿瘤细胞异质性。
Sci Transl Med. 2010 Apr 21;2(28):28ps19. doi: 10.1126/scitranslmed.3001056.
10
Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.肿瘤异质性在耐药性发展中的作用：呼吁精准治疗。
Semin Cancer Biol. 2017 Feb;42:13-19. doi: 10.1016/j.semcancer.2016.11.006. Epub 2016 Nov 10.
本文引用的文献
1
Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.CDO1 基因的表观遗传状态可能反映结肠癌术后辅助化疗的化疗敏感性。
Ann Surg Oncol. 2019 Feb;26(2):406-414. doi: 10.1245/s10434-018-6865-z. Epub 2018 Oct 11.
2
Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.结直肠肿瘤癌变过程中胱硫醚双加氧酶 1（CDO1）基因启动子甲基化。
PLoS One. 2018 May 10;13(5):e0194785. doi: 10.1371/journal.pone.0194785. eCollection 2018.
3
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.原发性胆囊癌和胆囊疾病中半胱氨酸双加氧酶1（CDO1）基因启动子DNA高甲基化的预后意义
PLoS One. 2017 Nov 21;12(11):e0188178. doi: 10.1371/journal.pone.0188178. eCollection 2017.
4
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma.II期结肠癌的辅助化疗：一个临床难题。
J Oncol Pract. 2017 Apr;13(4):233-241. doi: 10.1200/JOP.2016.017210.
5
PARP inhibitors: Synthetic lethality in the clinic.聚（ADP-核糖）聚合酶抑制剂：临床中的合成致死性
Science. 2017 Mar 17;355(6330):1152-1158. doi: 10.1126/science.aam7344. Epub 2017 Mar 16.
6
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.HER2阳性早期乳腺癌辅助化疗后曲妥珠单抗的11年随访：HERceptin辅助治疗（HERA）试验的最终分析
Lancet. 2017 Mar 25;389(10075):1195-1205. doi: 10.1016/S0140-6736(16)32616-2. Epub 2017 Feb 17.
7
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.CDO1启动子甲基化与基因沉默相关，是前列腺癌患者无生化复发生存的预后生物标志物。
Epigenetics. 2016 Dec;11(12):871-880. doi: 10.1080/15592294.2016.1241931. Epub 2016 Sep 30.
8
Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.CDO1基因启动子DNA甲基化及其在食管鳞状细胞癌中的临床意义
Dis Esophagus. 2017 Feb 1;30(2):1-9. doi: 10.1111/dote.12496.
9
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.CDX2作为II期和III期结肠癌的预后生物标志物
N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.
10
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.原发性乳腺癌中半胱氨酸双加氧酶1（CDO1）基因启动子DNA高甲基化的预后意义
PLoS One. 2016 Jan 19;11(1):e0144862. doi: 10.1371/journal.pone.0144862. eCollection 2016.
Zotero 插件